Search

Your search keyword '"Sweetenham, J."' showing total 318 results
Start Over Author "Sweetenham, J."

Refine your results

318 results on '"Sweetenham, J."'

10. Stromal gene signatures in large-B-cells lymphomas

Author

Lenz, G., Wright, G., Dave, S.S., Xiao, W., Powell, J., Zhao, H., Tan, B., Xu, W., Goldschmidt, N., Iqbal, J., Vose, J., Bast, M., Fu, K., Weisenberger, D.D., Greiner, T.C., Armitage, J.O., Kyle, A., May, L., Gascoyne, R.D., Troen, G., Connors, J.M., Holte H., Kvaloy, S., Dierickx, D., Verhoef, G., Delabie, J., Smeland, E.B., Jares, P., Martinez, A., Lopez-Guillermo, A., Montserrat, E., Campo, E., Braziel, R.M., Miller, T.P., Rimza, L.M., Cook, J.R., Pohlman, B., Sweetenham, J., Tubbs, R.R., Fisher, R.I., Hartmann, E., Rosenwald, A., Ott, G., Muller-Hermelink, H.-K., Wrench, D., Lister, T.A., Jaffe, E.S., Wilson, W.H., Chan, W.C., and Staudt, L.M.

Subjects
Lymphomas -- Research, Lymphomas -- Genetic aspects, Lymphomas -- Care and treatment
Abstract

A study was conducted to evaluate whether gene expression signatures help in improving overall survival among patients with diffuse large-B-cells lymphomas. Results indicated that survival is affected by differences in immune cells, fibrosis and angiogenesis.

Published
2008

28. IMMUNOTHERAPY OF MANTLE CELL LYMPHOMA (MCL), LYMPHOPLASMACYTOID LYMPHOMA (LPC) AND WALDENSTROM'S MACROGLOBULINEMIA (WM), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL) WITH RITUXIMAB (IDEC-C288): PRELIMINARY RESULTS OF AN ONGOING INTERNATIONAL MULTICENTRE TRIAL

Author

Foran, J. M., Rohatiner, A. Z. S., Cunningham, D., Popescu, R., Solai-Celigny, P., Cavalli, F., Coiffier, B., Johnson, P., Gisselbrecht, C., Haioun, C., Bessell, E., Sweetenham, J., Radford, J., Benzohra, A., and Lister, T. A.

Published
1998

30. Impact of the Affordable Care Act and Medicaid Expansion on Insurance Coverage and Outcomes in Patients with HIV‐associated Aggressive B‐cell Non‐Hodgkin Lymphomas.

Author

Premnath, N., Reves, H., Pandey, U., Anderson, J., Afrough, A., Anderson, L. D., Madanat, Y. F., Collins, R. H., Chung, S., Kaur, G., Khan, A., Kumar, K. A., Wolfe, H. R., Yilmaz, E., Awan, F. T., Sweetenham, J., and Geethakumari, P. Ramakrishnan

Subjects
PATIENT Protection & Affordable Care Act, INSURANCE, MEDICAID, LYMPHOMAS, TREATMENT effectiveness
Abstract

B Introduction: b HIV-associated lymphomas affect a uniquely disadvantaged group of patients, who were often denied insurance based on preexisting conditions until the Affordable Care Act (ACA) was signed in 2010. Impact of the Affordable Care Act and Medicaid Expansion on Insurance Coverage and Outcomes in Patients with HIV-associated Aggressive B-cell Non-Hodgkin Lymphomas We investigated the impact of ACA and its Medicaid expansion in 2014 which covered the low-income strata, on outcomes among patients with HIV-associated aggressive B-cell non-Hodgkin lymphomas (HIV-aB-NHL). [Extracted from the article]

Published
2023
Full Text
View/download PDF

33. Lymphomas

Author

Sweetenham, J. W. and Sweetenham, J. W.

Subjects
Lymphomas, Stem cells--Transplantation
Abstract

Emerging Cancer Therapeutics is a trinary hard cover periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists involved in the care of patients receiving cancer treatment. It will serve as both a reference and instructional tool for students, housestaff, fellows, practicing clinical oncologists, radiation oncologists, surgical oncologists, cancer biologists, and interdisciplinary colleagues throughout the oncology spectrum. With contributions from internationally recognized experts, Lymphomas combines chapters on the evolving role of established therapies such as stem cell transplantation with other disease-oriented chapters describing pathway-directed agents and the evolving paradigm of'personalized'lymphoma treatment. Coverage includes discussion of molecular characterization for different disease-specific lymphoma subtypes and the potential for developing'personalized'treatment as well as reviewing the evolving role of conventional chemotherapy, stem cell transplantation, and other salvage treatments. The articles examine a range of lymphoma subtypes, including Hodgkin lymphoma, T-cell lymphoma, aggressive B-cell lymphoma, and others.

Published
2012

34. Autologous stem cell transplantation for malignancy: a systematic review of the literature

Author

Simnett, S.J., Stewart, L. A., Sweetenham, J., Morgan, G., and Johnson, Peter W.M.

Subjects
hemic and lymphatic diseases
Abstract

A systematic review of the literature was undertaken to assess what published evidence is currently available to support the increasing use of autologous stem cell transplantation (ASCT), and to evaluate the published data with regard to the comparative cost of high-dose and conventional therapy. The review aimed to identify all published, randomized controlled trials (RCTs) comparing high-dose therapy (HDT) with ASCT versus conventional chemotherapy (CC) in acute lymphoblastic leukaemia, non-Hodgkin's lymphoma, Hodgkin's disease, multiple myeloma, and breast, lung, testicular and ovarian cancer. The review also aimed to identify all studies that had compared the cost of the two treatment strategies. Reports were identified by systematic searches of Cancerlit, Embase and Medline, and handsearching of several conference proceedings. Where possible, pooled odds ratios (ORs) were calculated according to the fixed-effect model. A total of 18 randomized trials were identified in acute lymphoblastic leukaemia, non-Hodgkin's lymphoma, Hodgkin's disease, multiple myeloma, and breast, lung and testicular cancer. Trials were generally small and no disease site had sufficient information to determine reliably whether high-dose therapy with autologous transplant is more effective than CC. Five studies were identified that compared the cost of the two treatments. These found the cost of HDT to be between one and four times higher than that of CC. Further randomized trials are required. Where appropriate, these should include economic assessment and assessments of long-term toxicity.

Published
2000

35. Lymphoma

Author

Hatton, Chris, Collins, Graham, Sweetenham, J. W., Hatton, Chris, Collins, Graham, and Sweetenham, J. W.

Subjects
Lymphomas, Lymphomas--Treatment
Abstract

Lymphomas arise from a single abnormal lymphocyte, yet many different subtypes of lymphoma occur. Recent advances in cellular and molecular techniques have revolutionized physicians'understanding of this malignancy, and there have been dramatic developments in diagnosis and treatment. Fast Facts: Lymphoma gives a comprehensive and up-to-date perspective on this challenging disease written by three experts in the field. Starting with a clear outline of the nature of lymphoma, its diagnosis, staging and management, this concise handbook goes on to provide specific details of individual lymphoma entities and treatment modalities. Fast Facts: Lymphoma is a valuable handbook for training doctors and specialist nurses working in the field of hemato-oncology, and will be of interest to the inquiring patient or carer who wishes to know more about lymphoma.

Published
2008

38. Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia

Author

Mahindra, A, primary, Bolwell, B J, additional, Rybicki, L, additional, Elder, P, additional, Kalaycio, M, additional, Dean, R, additional, Avalos, B, additional, Sobecks, R, additional, Tench, S, additional, Andresen, S, additional, Pohlman, B, additional, Sweetenham, J, additional, Devine, S, additional, and Copelan, E, additional

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results